alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Forensic Drug & Toxin 

Measurements
Material

Measurement

in Forensic Science

Need. 

• To ensure the accuracy and reliability of 

forensic results and measurements 

• To create improved methods in forensic 

analysis

Objectives

• Improving Analytical Capabilities in 

Three Forensic Science Program Areas

• Drugs and Toxins 

• Trace Evidence

• Human Identity (DNA)

• Develop measurement toolset

• Methods, Reference Materials and Data 

for Forensics

• Enable quantifiable uncertainty of 

measurements

• Improved efficiency/cost effectiveness

Customers and Partners

DNA profile generated 4X faster

Reliable ID of gunshot residue

SWGDRUG

Combined Chemical 

and Biometric 

Analysis of 

Fingerprint Lifts 

Synthetic 

Cannabinoid 

Structure & 

Analysis
Drugs & Toxins

 Mass Spectrometry of Drugs 

• Improved reference data and 

approaches to uncertainty of 

identification

 NMR of Drugs

• Develop approaches to reliable 

identification of drugs

• Testing benchtop NMR 

• Rapid Identification of Emerging 

Synthetic Drugs

• Synthetic drugs are constantly changing 

and their structures must be measured

 Marijuana Breathalyzer

• Growing decriminalization and 

legalization of marijuana

• Need for a test for auto/truck driver 

intoxication

• Field screening approaches

SensAbuesTM filter holder

AM-2201, 

a synthetic 

cannabinoid 
Strategy for Drugs & Toxins

• Mass spectral database

• Field tests

• Inkjet materials (trace evidence talk)

• Possible Fentanyl analysis web 

resource

• For both qualitative and quantitative 

analysis

• Desktop & handheld technologies

• Reduced consumption of reference 

materials

• Develop 

measurement 

toolset

• Methods, Reference 

Materials and Data 

for Forensics

• Enable quantifiable 

uncertainty of 

measurements

• Improve the 

efficiency/cost 

effectiveness
ILLICIT DRUGS AND TOXINS

• 3:40 pm – 4:00 pm William Wallace 

– Gas Chromatography Mass Spectrometry (GCMS) Libraries for the Identification of 

Controlled Substances

• 4:00 pm – 4:20 pm Tara Lovestead

– A Better Understanding of Cannabis 

Chemistry to aid in Vapor Phase Detection

• 4:20 pm – 4:40 pm Aaron Urbas

– NMR in Forensic Drug Analysis

• 4:40 pm – 4:50 pm Q&A SESSION
<PAGE>

                      STATEMENT RE COMPUTATION OF RATIOS




                                                                   EXHIBIT 12.01


         METROPOLITAN MORTGAGE & SECURITIES CO., INC. AND SUBSIDIARIES
               COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
                         AND PREFERRED STOCK DIVIDENDS

     The ratio of adjusted earnings to fixed charges and preferred stock
dividends was computed using the following tabulations to compute adjusted
earnings and the defined fixed charges and preferred stock dividends.

<TABLE>
<CAPTION>


                                            Year Ended September 30
                                ------------------------------------------------
<S>                             <C>        <C>       <C>       <C>       <C>
                                             (Dollars in Thousands)
                                  1999       1998      1997      1996      1995
                                --------   -------   -------   -------   -------

Net income                      $ 16,275   $10,327   $ 9,668   $ 8,038   $ 6,303
Add:
  Interest                        22,388    19,663    19,375    18,788    16,381
  Taxes (benefit) on income      (12,577)    5,475     5,073     4,235     3,108
                                --------   -------   -------   -------   -------
Adjusted earnings               $ 26,086   $35,465   $34,116   $31,061   $25,792
                                ========   =======   =======   =======   =======
Preferred stock dividend
  requirements                  $  3,642   $ 3,732   $ 4,113   $ 3,868   $ 4,038
Ratio factor of income after
  provision for income taxes
  to income before provision
  for income taxes                   100%       66%       66%       66%       67%
Preferred stock dividend
  factor on pretax basis           3,642     5,687     6,244     5,880     6,006
Fixed charges
  Interest                        22,388    19,663    19,375    18,788    16,381
  Capitalized interest               936       611       521     2,468     2,730
                                --------   -------   -------   -------   -------
Fixed charges and
  preferred stock
  dividends                     $ 26,966   $25,961   $26,140   $27,136   $25,117
                                ========   =======   =======   =======   =======
Ratio of adjusted earnings
  to fixed charges and
  preferred stock dividends         *         1.37      1.31      1.14      1.03
</TABLE>
------------
* Earnings were insufficient to meet fixed charges and preferred stock dividends
by approximately $808,000 for the year ended September 30, 1999.
<PAGE>   1

                                                                    EXHIBIT 23.1



                       CONSENT OF INDEPENDENT ACCOUNTANTS


   
We hereby consent to the use in the Prospectus constituting part of this
Registration Statement on Form S-1 of our report dated February 1, 1998, except
as to Note 10, which is as of July 9, 1998, relating to the financial
statements of broadcast.com, which appears in such Prospectus. We also consent
to the application of such report to the Financial Statement Schedule for the
period from May 19, 1995 (inception) to December 31, 1995 and the two years
ended December 31, 1997 listed under Item 16 (b) of this Registration Statement
when such schedule is read in conjunction with the financial statements referred
to in our report. The audits referred to in such report also included this
schedule. We also consent to the references to us under the headings "Experts"
and "Selected Financial Data" in such Prospectus. However, it should be noted
that PricewaterhouseCoopers LLP has not prepared or certified such "Selected
Financial Data."
    




PricewaterhouseCoopers LLP

Dallas, Texas
July 9, 1998
Version 1 / Date of Issue: 10.29.15 / Issuing Authority: Forensic Science Standards Board (FSSB)

OSAC Research Needs Assessment Form

Title of research need:

Keywords:

Submitting subcommittee(s): Date Approved:

(If SAC review identifies additional subcommittees, add them to the box above.)

Background information:

1. Description of research need:

2. Key bibliographic references relating to this research need:

3a. In what ways would the research results improve current laboratory capabilities?

There is a lack of understanding of the degree of cognitive bias that may be associated with high 

throughput disaster victim identification operations. There are two closely associated research 

needs:

• Determine if cognitive bias exists in current DVI operations 

• Develop effective mitigation strategies 

None

Understanding the presence (and extent) of cognitive bias and its potential impact on postmortem 

processing of human remains and victim identification is essential for developing strategies to 

mitigate any negative impact of bias. 

Understanding cognitive bias in DVI operations

Disaster victim identification, mass fatality, cognitive bias

Disaster Victim Identification 8/24/2016
Version 1 / Date of Issue: 10.29.15 / Issuing Authority: Forensic Science Standards Board (FSSB)

3b. In what ways would the research results improve understanding of the scientific basis for the 

subcommittee(s)?

3c. In what ways would the research results improve services to the criminal justice system?

4. Status assessment (I, II, III, or IV): 

This research need has been identified by one or more subcommittees of OSAC and is being provided as an 

informational resource to the community.

Major gap 

in current 

knowledge

Minor gap 

in current 

knowledge

No or limited

current research 

is being 

conducted

I III

Existing current 

research is being 

conducted

II IV

The subcommittee will benefit from this research by enhancing the DVI community’s 

understanding of the role and extent of cognitive bias in DVI operations. With these research 

results, the subcommittee can develop standards and best practices to support medicolegal 

jurisdictions in their attempts to reduce the introduction and limit the effects of cognitive bias in 

DVI management. 

Implement additional protective and quality assurance measures to reduce or eliminate cognitive 

bias in disaster victim identification. 

 I
Version 1 / Date of Issue: 10.29.15 / Issuing Authority: Forensic Science Standards Board (FSSB)

// Approval date:

(Approval is by majority vote of subcommittee. Once approved, forward to SAC.)

1. Does the SAC agree with the research need? Yes ⃝ No ⃝ 

2. Does the SAC agree with the status assessment? Yes ⃝ No ⃝

If no, what is the status assessment of the SAC:

Approval date:

(Approval is by majority vote of SAC. Once approved, forward to NIST for posting.)

Subcommittee

SAC
<PAGE>

                                                                    EXHIBIT 32.1

Certification Pursuant to 18 U.S.C. Section 1350 As Adopted Pursuant to Section
906 of the Sarbanes-Oxley Act of 2002

I, Hoolae Paoa, Chief Executive Officer of Mid-State Raceway, Inc. and
Subsidiary (the "Company"), certify, pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

(1)the Annual Report on Form 10-K of the Company for the year ended December 31,
2000 (the "Report") fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934, as amended (15 U.S.C. 78m or
78o(d)); and

(2)the information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

Date: January 10, 2004

/s/ Hoolae Paoa
Hoolae Paoa
Chief Executive Officer

                                                                              50
<PAGE>   1
 
                                                                    EXHIBIT 23.5
 
                       CONSENT OF INDEPENDENT ACCOUNTANTS
 
     We consent to the inclusion in this Registration Statement on Form S-4 of
Remington Oil and Gas Corporation (formerly Box Energy Corporation) of our
report dated March 5, 1996, except for the thirteenth paragraph of Note 1 as to
which the date is March 27, 1998, on our audit of the financial statements of
Remington Oil and Gas Corporation for the year ended December 31, 1995. We also
consent to the reference to our firm under the caption "Experts."
 
                                            PRICEWATERHOUSECOOPERS LLP
 
   
Dallas, Texas
October 14, 1998
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Securities and Exchange Commission

Notice is hereby given, pursuant to the provisions of the Government in the Sunshine Act, Public Law 94-409, that the Securities and Exchange Commission will hold a Closed Meeting on Thursday, December 4, 2014 at 2 p.m.

Commissioners, Counsel to the Commissioners, the Secretary to the Commission, and recording secretaries will attend the Closed Meeting. Certain staff members who have an interest in the matters also may be present.

The General Counsel of the Commission, or her designee, has certified that, in her opinion, one or more of the exemptions set forth in 5 U.S.C. 552b(c)(3), (5), (7), 9(B) and (10) and 17 CFR 200.402(a)(3), (5), (7), 9(ii) and (10), permit consideration of the scheduled matter at the Closed Meeting.

Commissioner Aguilar, as duty officer, voted to consider the items listed for the Closed Meeting in closed session, and determined that no earlier notice thereof was possible.

The subject matter of the Closed Meeting will be:

Institution and settlement of injunctive actions;

Institution settlement of administrative proceedings;

Settlement of injunctive actions;

Litigation matter; and

Other matters relating to enforcement proceedings.

At times, changes in Commission priorities require alterations in the scheduling of meeting items.

For further information and to ascertain what, if any, matters have been added, deleted or postponed, please contact the Office of the Secretary at (202) 551-5400.

Dated: December 1, 2014.

Brent J. Fields, 

Secretary.

[FR Doc. 2014-28532 Filed 12-1-14; 4:15 pm]

BILLING CODE 8011-01-P
11658.

#### Waxelbaum & Brothers Incorporated *v.*Livingston.

Decided October 13, 1920.

Complaint; from Webster superior court — Judge Littlejohn. May 22, 1920.

*M. A. Walker,*for plaintiff in error.

*J. F. Souter,*contra.

Smith, J.

While the evidence waa conflicting, there was ample evidence to support the verdict rendered, and, the motion for a new trial being based on general grounds only, this court cannot interfere with the judgment of the lower court overruling the motion for a new trial.

*Judgment affirmed.*

*Jenkins, P. J., and Stephens, J., concur.*
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

                    The meeting will be closed to the public in accordance with the                           ( print page 74734)                        provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.                

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel NIAID Clinical Trial Implementation Cooperative Agreement (U01) and NIAID Clinical Trail Implementation Grant (R01).                    

*Date:*                         January 9, 2015.                    

*Time:*                         1:00 p.m. to 3:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20852 (Telephone Conference Call).                    

*Contact Person:*                         Jane K. Battles, Ph.D., Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers lane Room F30B, Rockville, MD 20852, 240-669-5029, battlesja@mail.nih.gov.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: December 10, 2014.

David Clary, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2014-29321 Filed 12-15-14; 8:45 am]

BILLING CODE 4140-01-P
```

[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4803 Introduced in House (IH)]

108th CONGRESS
  2d Session
                                H. R. 4803

   To designate the memorial to Edmund S. Muskie located in Rumford, 
                     Maine, as a national memorial.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              July 9, 2004

 Mr. Michaud introduced the following bill; which was referred to the 
                         Committee on Resources

_______________________________________________________________________

                                 A BILL

 
   To designate the memorial to Edmund S. Muskie located in Rumford, 
                     Maine, as a national memorial.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. DESIGNATION OF NATIONAL MEMORIAL TO VETERAN EDMUND S. 
              MUSKIE.

    (a) Designation.--The memorial to Edmund S. Muskie located in 
Rumford, Maine, is hereby designated as the ``Edmund S. Muskie National 
Memorial''.
    (b) Administration.--The memorial referred to in subsection (a) is 
hereby a unit of the National Park System. The Secretary of the 
Interior shall administer the memorial in accordance with the laws 
generally applicable to units of the National Park System.
                                 <all>
```
C OURT OF A PPEALS FOR THE

F IRST D ISTRICT OF T EXAS AT H OUSTON

O RDER

Appellate case name: Victor S. Elgohary, Individually and r epresentatively on behalf of Nominal Defendant Lakes on Eldridge North Community Association, Inc. v. Lakes on Eldridge North Community Association, Inc.; RealManage, LLC; Darla Kitchen; Don Byrnes; Michael Ecklund; Laura Vasallo Lee;
John Kane; Julie Ann Bennett; Rick Hawthorne; Cara Davis; Christi Keller; Jim Flanary; Jill Richardson ; Neil McLaurin; and Walter Spears

Appellate case number: 01

- 14

- 00216

- CV

Trial court case number: 2013

- 17221

Trial court: 234th District Court of Harris County

Appellant, Victor S. Elgohary, has filed a “Motion to Extend Time to Appoint a Replacement Mediator, Order All Parties to Mediation and Abate the Appellate Timelines.” We grant in part and deny in part.

In his motion, appellant informs the Court that the parties’ agreed

- upon mediator, Judge Davie Wilson, is no longer able to mediate this case. Appellant therefore requests an extension of time for the parties “to locate and agree on a new mediator and file a new mediator’s report.” Appellant further reque sts “an abatement of the deadlines for the reporter’s record and the clerk’s record until 60 days after the mediation has concluded in order to mitigate costs while the parties attempt to mediate the dispute.” Finally, appellant requests that we “order th at all parties along with their respective insurance carriers and attorneys be present at the mediation.”

To the extent that appellant seeks new deadlines related to mediation, we grant the motion. The parties shall (1) file a completed “Parties’ Notifica tion to Court of Mediator” with the Clerk of this Court within 15 days of the date of this order, (2) conduct the mediation within 45 days of the date of this order, and (3) advise the Clerk of this Court in writing whether the parties did or did not settl e the underlyingdispute no later than two days after the conclusion of the mediation. Further, the

mediator shall also advise the Court of the outcome of the mediation within two days after the conclusion of the mediation and shall file a completed “Appo intment and Fee Report

— Mediation” form with the Clerk of this Court.

To the extent that appellant seeks abatement of the deadlines for filing the reporter’s and clerk’s records, we informed the parties in our mediation referral order that “[n]othing in thi s order modifies the timetables in the Texas Rules of Appellate

Procedure.” Further, the appellate record is not required to be filed until July 11, 2014.

See T EX

. R. A PP

. P . 35.1(a). Accordingly, we deny the motion.

Finally, we deny appellant’ s request that we order all parties and their insurance carriers and attorneys to “be present at the mediation.”

It is so ORDERED.

Judge’s signature: /s/ Sherry Radack

 Acting individually  Acting for the Court

Date: May 20, 2014
#### UNITED STATES of America, Plaintiff-Appellee, v. Anthony Darnell McLEAN, Defendant-Appellant.

No. 00-4603.

United States Court of Appeals, Fourth Circuit.

Submitted April 27, 2001.

Decided May 17, 2001.

Michael S. Arif, Martin, Arif, Petrovich & Walsh, Springfield, VA, for appellant.

Helen F. Fahey, United States Attorney, William E. Fitzpatrick, Assistant United States Attorney, Alexandria, VA, for appellee.

*124Before WILLIAMS, TRAXLER, and GREGORY, Circuit Judges.

PER CURIAM.

Anthony Darnell McLean appeals his conviction for carrying a firearm in furtherance of a drug trafficking offense, in violation of 18 U.S.C.A. § 924(c) (West 2000).* McLean alleges that the evidence at trial was not sufficient to support his conviction. We find the evidence at trial was sufficient to find that the firearm found under McLean’s car seat belonged to him and that it was used in furtherance of a drug trafficking offense, and therefore there was sufficient evidence to support the conviction. *See Glasser v. United States,*315 U.S. 60, 80, 62 S.Ct. 457, 86 L.Ed. 680 (1942) (stating that “[t]he verdict of a jury must be sustained if there is substantial evidence, taking the view most favorable to the Government, to support it”); *United States v. Mitchell,*104 F.3d 649, 652-54 (4th Cir.1997) (discussing evidence necessary to establish violation of 18 U.S.C.A. § 924(c)).

We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

*AFFIRMED.*

*

 McLean pled guilty to possession with intent to distribute fifty grams or more of crack cocaine, in violation of 21 U.S.C.A. § 841(a)(1) (West 1999). He proceeded to a bench trial on the second count in the indictment.
Exhibit 10.25


SUMMARY OF THE COMPANY’S NON-EMPLOYEE DIRECTOR
COMPENSATION


Non-employee directors are paid $2,000 for each Board
meeting attended in person, $1,000 per Board meeting conducted by telephone,
$1,500 for each Audit Committee meeting attended, whether in person or by
phone, $1,000 for each Compensation Committee, Nominating Committee or Special
Committee meeting attended in person and $500 for each Compensation Committee,
Nominating Committee or Special Committee meeting conducted by telephone. In
addition, the Chairman of the Audit Committee is paid an additional fee of
$8,000 per year and the Compensation Committee Chairman is paid an additional
fee of $4,000 per year for their services as such. All directors are reimbursed
for their reasonable expenses related to attendance at meetings.


In accordance with the Company’s 2000 Director Stock
Option Plan, any non-employee director first elected to the Board will receive
a stock option award of 50,000 shares. Each year, as of the Annual Meeting of
Stockholders, each non-employee director will receive a stock option award of
15,000 shares.